Management of Le Fort I fracture

por Kim, Hak Su, Kim, Seong Eun, Lee, Hyun Tae
Publicado 2017

Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology

por Lee, Hyun Tae, Lee, Sang Hyung, Heo, Yong-Seok
Publicado 2019

Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis

por Lim, Heejin, Lee, Sang Hyung, Lee, Hyun Tae, Lee, Jee Un, Son, Ji Young, Shin, Woori, Heo, Yong-Seok
Publicado 2018

The High-Resolution Structure Reveals Remarkable Similarity in PD-1 Binding of Cemiplimab and Dostarlimab, the FDA-Approved Antibodies for Cancer Immunotherapy

por Jeong, Tae-Jun, Lee, Hyun-Tae, Gu, Nahyeon, Jang, Yu-Jeong, Choi, Seung-Beom, Park, Ui-Beom, Lee, Sang-Hyung, Heo, Yong-Seok
Publicado 2022

Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab

por Lee, Hyun Tae, Lee, Ju Yeon, Lim, Heejin, Lee, Sang Hyung, Moon, Yu Jeong, Pyo, Hyo Jeong, Ryu, Seong Eon, Shin, Woori, Heo, Yong-Seok
Publicado 2017

BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus

por Shin, Woori, Lee, Hyun Tae, Lim, Heejin, Lee, Sang Hyung, Son, Ji Young, Lee, Jee Un, Yoo, Ki-Young, Ryu, Seong Eon, Rhie, Jaejun, Lee, Ju Yeon, Heo, Yong-Seok
Publicado 2018

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy

por Lee, Ju Yeon, Lee, Hyun Tae, Shin, Woori, Chae, Jongseok, Choi, Jaemo, Kim, Sung Hyun, Lim, Heejin, Won Heo, Tae, Park, Kyeong Young, Lee, Yeon Ji, Ryu, Seong Eon, Son, Ji Young, Lee, Jee Un, Heo, Yong-Seok
Publicado 2016